Obsidian, Galera to advance cell therapy following reverse merger

The combined company will trade on the Nasdaq under the ticker OBX. It has also secured commitments for a private placement ...
Fierce Biotech

Cell therapy biotech Obsidian leverages Galera reverse merger to go public

After initiating a wind-down more than 18 months ago and exploring liquidation, Galera Therapeutics has found a path forward ...
PharmExec

Obsidian Therapeutics and Galera Therapeutics Enter $350 Million Merger Agreement

A reverse-merger structure uses Galera’s public listing and cash to bring Obsidian public, while Madan Jagasia is slated to ...
Share Prices

RTW Biotech rises as cancer therapy firm agrees to reverse merger

RTW Biotech Opportunities on Wednesday welcomed news of a reverse merger between its portfolio company Obsidian Therapeutics Inc and Galera Therapeutics Inc. The Guernsey-based investor in the life ...